| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1996-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dfd07e1663eba0b4ce8bdbe821775c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f49d8e3e6363c1d1809858a7a5cb0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0350097d37950505655697aed25cc72c |
| publicationDate |
1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5916888-A |
| titleOfInvention |
Imidazo 1,5A!pyridine derived serine protease inhibitors |
| abstract |
The invention relates to an imidazole 1,5a!pyridine derived serine protease inhibitor comprising a unit having general formula (I) ##STR1## wherein R 1 is hydrogen, lower alkyl or an acyl group; R 2 is hydrogen or lower alkyl; R 3 and R 4 are independently hydrogen, lower alkyl or together form ═CH--NR 5 NR 6 , R 5 and R 6 being lower alkyl. The compounds are serine protease inhibitors and can be used for the treatment and prophylaxis of thrombosis and thrombin-associated diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008161556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6358928-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004018984-A1 |
| priorityDate |
1995-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |